Clinical Trial

HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study plans to enroll a total of 208 patients with Acute Ischemic Stroke (AIS) who present within 4.5 to 24 hours of symptom onset and meet the specified imaging criteria.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-14; most recent amendment 2026-06-25.
Status change: Recruiting → Active, Not Recruiting 2026-06-25
Status change: Not Yet Recruiting → Recruiting 2025-11-18
Trial Details
NCT Number NCT07233070
Lead Sponsor Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions Acute Ischemic Stroke
Enrollment 210 participants
Start Date 2025-10-31
Primary Completion 2026-10 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-29